Effect of Food on the Oral Bioavailability of a Prolonged release Vamifeport in Healthy Volunteers
Research type
Research Study
Full title
A Phase 1, Randomized, Open-label Study to Characterize the Effect of Food on the Oral Bioavailability of a Prolonged Release Formulation of Vamifeport in Healthy Adult Subjects
IRAS ID
1011583
Contact name
Joanna Rutecka
Contact email
Sponsor organisation
CSL Behring LLC
Clinicaltrials.gov Identifier
Research summary
This is a phase I, single-center, randomized, open-label, single-dose, 2-way, 2-period, crossover study to evaluate the effect of food on the pharmacokinetics (PK) of vamifeport prolonged-release (PR) formulation in healthy adult participants. Participants will be randomly allocated to one of two treatment sequences.
REC name
East of England - Cambridge Central Research Ethics Committee
REC reference
25/EE/0024
Date of REC Opinion
9 Apr 2025
REC opinion
Further Information Favourable Opinion